## CONSOLIDATED STATEMENT OF CASH FLOWS

For the year ended 31 March 2024

|                                                      | Note   | 31 March 2024 £   | 31 March 2023 £   |
|------------------------------------------------------|--------|-------------------|-------------------|
| Cash flows from operating activities                 |        |                   |                   |
| (Loss)/profit before income tax                      |        | (15,910,103)      | (18,562,346)      |
| Adjustments for:                                     |        |                   |                   |
| Depreciation and amortisation                        |        | 1,578,916         | 2,839,889         |
| Disposal of PPE                                      |        | (650)             | -                 |
| Share based payments                                 | 23     | -                 | 1,605             |
| Impairments                                          |        | 15,317,338        | 16,558,296        |
| Net finance (income)/costs                           |        | 130,546           | 81,518            |
| Gain on disposal of subsidiaries                     |        | (164,300)         |                   |
| Provision for deferred tax liabilities               |        | (1,485,096)       | (1,573,992)       |
| Changes in working capital:                          |        |                   |                   |
| (Increase)/Decrease in trade and other receivables   |        | 394,606           | (433,296)         |
| Increase/(Decrease) in trade and other payables      |        | (160,651)         | 121,131           |
| Net cash used in operating activities                |        | (299,394)         | (967,195)         |
| Cash flows from investing activities                 |        |                   |                   |
| Sale/(Purchase) of property, plant and equipment     | 12     | 837               | (8,788)           |
| Purchase of intangible assets                        | 14     | (1,020,516)       | (1,456,436)       |
| Net cash from disposal of subsidiaries               |        | 187,204           | -                 |
| Net cash used in investing activities                |        | (832,475)         | (1,465,224)       |
| Cash flows from financing activities                 |        |                   |                   |
| Proceeds from issue of share capital                 |        | 900,000           | -                 |
| Proceeds from Borrowings                             |        | -                 | 2,250,000         |
| Repayment of leasing liabilities                     |        | (10,868)          | (10,387)          |
| Net cash generated from financing activities         |        | 889,132           | 2,239,613         |
| Net decrease/(increase) in cash and cash equivalents |        | (242,737)         | (192,806)         |
| Cash and cash equivalents at beginning of year       |        | 280,584           | 473,390           |
| Cash and cash equivalents at end of year             | 17     | 37,847            | 280,584           |

<!-- image -->

<!-- image -->

## COMPANY STATEMENT OF CASH FLOWS

For the year ended 31 March 2024

Company

<!-- image -->

|                                                      | Note   | 31 March 2024 £   | 31 March 2023 £   |
|------------------------------------------------------|--------|-------------------|-------------------|
| Cash flows from operating activities                 |        |                   |                   |
| (Loss)/profit before income tax                      |        | (17,185,547)      | (21,180,437)      |
| Adjustments for:                                     |        |                   |                   |
| Share based payments                                 | 23     | -                 | 1,605             |
| Impairments                                          |        | 16,524,845        | 20,408,199        |
| Net finance (income)/costs                           |        | 95,760            | 63,566            |
| Changes in working capital:                          |        |                   |                   |
| (Increase)/Decrease in trade and other receivables   |        | (115,030)         | (62,285)          |
| Increase/(Decrease) in trade and other payables      |        | (5,914)           | 74,092            |
| Net cash used in operating activities                |        | (685,886)         | (695,260)         |
| Cash flows from investing activities                 |        |                   |                   |
| Loans granted to subsidiaries                        |        | (203,404)         | (1,612,305)       |
| Net cash used in investing activities                |        | (203,404)         | (1,612,305)       |
| Cash flows from financing activities                 |        |                   |                   |
| Proceeds from issue of share capital                 |        | 900,000           | -                 |
| Proceeds from Borrowings                             |        | -                 | 2,250,000         |
| Net cash generated from financing activities         |        | 900,000           | 2,250,000         |
| Net decrease/(increase) in cash and cash equivalents |        | 10,710            | (57,565)          |
| Cash and cash equivalents at beginning of year       |        | 3,749             | 61,314            |
| Cash and cash equivalents at end of year             | 17     | 14,459            | 3,749             |

<!-- image -->